A pilot study of safety and efficacy of HCV retreatment with sofosbuvir/velpatasvir/voxilaprevir in patients with or without HIV (RESOLVE STUDY)

Hepatitis C Articles (HCV)


A pilot study of safety and efficacy of HCV retreatment with sofosbuvir/velpatasvir/voxilaprevir in patients with or without HIV (RESOLVE STUDY)

	Download the PDF here On the 31st July, a Scottish Government Press release and an accompanying report from HPS on Scotland's Hepatitis C Elimination Strategy were published. The strategy outlines a government commitment to eliminate hepatitis C by 2024. https://news.gov.scot/news/eliminating-hepatitis-c https://hpspubsrepo.blob.core.windows.net/hps-website/nss/2840/documents/1_HCV-Elimination-Scotland-2019-07-31.pdf

View Older Articles

Back to Top

www.natap.org